Related Experiment Video
Updated: Jun 23, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Piperacillin-Tazobactam-Induced Immune Thrombocytopenia: A Case Report
1Department of Medicine, Division of Hospital Internal Medicine, 4352Mayo Clinic, Rochester, MN, USA.
Abstract:
Drug-induced immune thrombocytopenia is an isolated thrombocytopenia caused by accelerated platelet destruction from drug-dependent, platelet-reactive antibodies. Heparin-induced thrombocytopenia is the most common drug-induced immune thrombocytopenia. Common implicated antibiotics for drug-induced immune thrombocytopenia include ceftriaxone, trimethoprim-sulfamethoxazole, vancomycin, and penicillin. The platelet nadir can be less than 20 × 10 (9)/L and typically occurs within 1 to 2 weeks of exposure to the inciting drug. Although rare, drug-induced immune thrombocytopenia can be fatal. Diagnosis is made by excluding other causes of thrombocytopenia. Laboratory testing for drug-dependent antiplatelet antibodies is often helpful but not required. Thrombocytopenia typically improves within 1 to 2 days of drug discontinuation and platelet count returns to normal within a week. Identifying and discontinuing the implicated medication is key to prevention of serious complications. A patient case of drug-induced immune thrombocytopenia is described after initiation of empiric piperacillin-tazobactam for refractory right foot cellulitis in the setting of right fourth toe diabetic ulcer.
Insights
Drug-induced immune thrombocytopenia (DITP) occurs when drugs trigger antibodies that destroy platelets. Promptly stopping the offending drug is crucial for recovery and preventing severe complications.
Area of Science:
- Hematology
- Immunology
- Pharmacology
Background:
- Drug-induced immune thrombocytopenia (DITP) is a serious condition characterized by accelerated platelet destruction.
- It results from drug-dependent, platelet-reactive antibodies, with heparin-induced thrombocytopenia being the most common form.
- Antibiotics like ceftriaxone, trimethoprim-sulfamethoxazole, vancomycin, and penicillin are frequently implicated in DITP.
Observation:
- Thrombocytopenia in DITP can be severe, with platelet nadirs below 20 × 10^9/L.
- Onset typically occurs 1-2 weeks after exposure to the causative drug.
- A patient case illustrates DITP following piperacillin-tazobactam initiation for cellulitis in a diabetic foot ulcer.
Findings:
- Diagnosis involves excluding other causes of thrombocytopenia; laboratory testing for drug-dependent antiplatelet antibodies can be supportive but is not mandatory.
- Platelet counts usually improve within 1-2 days of drug discontinuation and normalize within a week.
- Identifying and discontinuing the implicated medication is the cornerstone of management.
Implications:
- DITP, though rare, can be fatal, underscoring the importance of timely diagnosis and intervention.
- Early recognition and withdrawal of the offending agent are critical for preventing serious complications.
- This case highlights the potential for piperacillin-tazobactam to induce DITP, emphasizing vigilance in patients with risk factors.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Acute Pyelonephritis II: Diagnostic Studies and Management

